The availability of donor organs is often a question of life and death for patients requiring a transplant. With transplantation now a commonplace technique, one of the main factors limiting the number of transplants is the shortage of organs. Continuous efforts are being made to address this shortage and make transplant systems more efficient and accessible.
In 2007, the European Commission highlighted the need to ensure greater availability of and accessibility to high quality and safe transplantation. In 2008, the Commission adopted an Action Plan to strengthen cooperation between EU countries in this area. In 2010, a new EU Directive defined standards of quality and safety for human organs intended for transplantation.
There have also been considerable advances in the therapeutic use of human tissue and cells. As a fast-growing field, it is crucial that the various substances and procedures are subject to European safety and quality requirements.
Shared solutions
Through the second EU health programme 2008-2013, the European Commission has co-funded, via its Consumers, Health and Food Executive Agency (Chafea), actions that can help improve transplant systems and increase the supply of organs.
In line with the EU Action Plan, support has been given to projects which advance cooperation on donation and transplantation. For example, projects supported have raised public awareness of organ donation, improved hospital-based systems for organ donation, facilitated the exchange of organs between EU countries, and promoted standards for living donor programmes.
To further improve transplant therapies, novel technologies have been developed and shared across borders, improving outcomes for recipients. Sharing scientific knowledge and clinical best practice in transplantation enhances the quality of all donated organs and increases life expectancy for all transplanted patients.
In addition to organ transplantation, the medical application of human tissues and cells (bone, skin, cardiac valves, haematopoietic stem cells, reproductive cells, etc.) is a strongly expanding field of medicine offering excellent opportunities for the treatment of many diseases. In order to minimise the risks associated with the application of donated tissues and cells, it is essential to ensure their quality and safety.
The EU Tissue and Cells Directives created a benchmark for the standards that must be met when carrying out any activity involving tissues and cells, from donation until human application.
The European Commission has supported EU countries in their efforts to implement the Directives by providing funding for several projects under the EU health programme. Working together to raise standards Organs are a scarce, life-saving resource for which demand is greater than supply. Despite this, sometimes organs cannot be transplanted in a country, when there is no suitable recipient on the waiting list or no transplant programme in place yet to perform such a transplant procedure. FOEDUS is a Joint Action which seeks to address this problem by facilitating the donation of organs from a donor in one EU country to a recipient in another.
Building on existing bilateral or multilateral collaborations and on previous European projects such as MODE and COORENOR, FOEDUS aims to enable EU countries to exchange more organs across borders, when needed, thus building upon the potential identified for substantial growth in cross-border organ exchange. This can help match the right organ with the right patient, minimising discard and reducing transplantation waiting lists.
It is crucial to ensure that living donors who are donating voluntarily are fully healthy and will be followed up in the long term. The EULID project, co-funded under the first EU health programme, was developed to build consensus in this area of living donation. The ELIPSY project built on EULID results to consolidate standards on the medical and psychosocial follow-up of living donors.
In addition, ELIPSY supported high quality living organ donation by creating a follow-up model to evaluate the psychosocial well-being and quality of life of living donors.
The results of EULID and ELIPSY will be shared widely in order to further contribute to improving the quality of living donation in Europe.
Visit: www.eulivingdonor.eu Improving how tissues establishments (TE) procure, process, preserve, store and distribute tissue for transplantation can increase the health and safety of recipients. Euro-GTPs aimed to develop and apply good tissue practices on a European-wide scale in order to improve the performance of TE personnel.
Improving vigilance and surveillance in tissue transplantation
The project analysed the current regulations and practices in TEs. From this, the partners devised detailed European Good Tissue Practices in areas such as ocular, cardiovascular, musculoskeletal and skin grafts. A training course for TE personnel was developed based on the GTPs.
By sharing these practices widely, the project helped to raise and harmonise standards of practice in areas such as donor selection, risk management and traceability.
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